Literature DB >> 12384341

Melanization of Cryptococcus neoformans and Histoplasma capsulatum reduces their susceptibilities to amphotericin B and caspofungin.

David van Duin1, Arturo Casadevall, Joshua D Nosanchuk.   

Abstract

The fungal pathogens Cryptococcus neoformans and n class="Species">Histoplasma capsulatum produce melanin-like pigments in the presence of L-dopa in vitro and during mammalian infection. We investigated whether melanization affected the susceptibilities of the fungi to amphotericin B, caspofungin, fluconazole, itraconazole, or flucytosine (5FC). Using the standard macrodilution MIC protocol (the M27A protocol) of the National Committee for Clinical Laboratory Standards for yeast, we found no difference in the susceptibilities of melanized and nonmelanized C. neoformans and H. capsulatum isolates. Killing assays demonstrated that melanization reduced the susceptibilities of both fungi to amphotericin B and caspofungin. Laccase-deficient C. neoformans cells grown with L-dopa were significantly more susceptible than congenic melanin-producing yeast to killing by amphotericin B or caspofungin. Preincubation of amphotericin B or caspofungin with melanins decreased their antifungal activities. Elemental analysis of melanins incubated with amphotericin B or caspofungin revealed an alteration in the C:N ratios of the melanins, which indicated binding of these drugs by the melanins. In contrast, incubation of fluconazole, itraconazole, or 5FC with melanins did not significantly affect the antifungal efficacies of the drugs or the chemical composition of the melanins. The results suggest a potential explanation for the inefficacy of caspofungin against C. neoformans in vivo, despite activity in vitro. Furthermore, the results indicate that fungal melanins protect C. neoformans and H. capsulatum from the activities of amphotericin B and caspofungin and that this protection is not demonstrable by standard broth macrodilution assays.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12384341      PMCID: PMC128748          DOI: 10.1128/AAC.46.11.3394-3400.2002

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  37 in total

1.  Glyphosate inhibits melanization of Cryptococcus neoformans and prolongs survival of mice after systemic infection.

Authors:  J D Nosanchuk; R Ovalle; A Casadevall
Journal:  J Infect Dis       Date:  2001-02-23       Impact factor: 5.226

2.  Comparison of the echinocandin caspofungin with amphotericin B for treatment of histoplasmosis following pulmonary challenge in a murine model.

Authors:  S Kohler; L J Wheat; P Connolly; C Schnizlein-Bick; M Durkin; M Smedema; J Goldberg; E Brizendine
Journal:  Antimicrob Agents Chemother       Date:  2000-07       Impact factor: 5.191

Review 3.  Melanin and virulence in Cryptococcus neoformans.

Authors:  A Casadevall; A L Rosas; J D Nosanchuk
Journal:  Curr Opin Microbiol       Date:  2000-08       Impact factor: 7.934

4.  Synthetic melanin suppresses production of proinflammatory cytokines.

Authors:  N Mohagheghpour; N Waleh; S J Garger; L Dousman; L K Grill; D Tusé
Journal:  Cell Immunol       Date:  2000-01-10       Impact factor: 4.868

5.  In vitro activities of voriconazole, itraconazole, and amphotericin B against Blastomyces dermatitidis, Coccidioides immitis, and Histoplasma capsulatum.

Authors:  R K Li; M A Ciblak; N Nordoff; L Pasarell; D W Warnock; M R McGinnis
Journal:  Antimicrob Agents Chemother       Date:  2000-06       Impact factor: 5.191

6.  Melanisation of Cryptococcus neoformans in human brain tissue.

Authors:  J D Nosanchuk; A L Rosas; S C Lee; A Casadevall
Journal:  Lancet       Date:  2000-06-10       Impact factor: 79.321

7.  Isolation and serological analyses of fungal melanins.

Authors:  A L Rosas; J D Nosanchuk; B L Gómez; W A Edens; J M Henson; A Casadevall
Journal:  J Immunol Methods       Date:  2000-10-20       Impact factor: 2.303

8.  Multicenter case-control study of risk factors for histoplasmosis in human immunodeficiency virus-infected persons.

Authors:  R A Hajjeh; P G Pappas; H Henderson; D Lancaster; D M Bamberger; K J Skahan; M A Phelan; G Cloud; M Holloway; C A Kauffman; L J Wheat
Journal:  Clin Infect Dis       Date:  2001-03-26       Impact factor: 9.079

9.  Anti-inflammatory and immunomodulating properties of grape melanin. Inhibitory effects on paw edema and adjuvant induced disease.

Authors:  N Avramidis; A Kourounakis; L Hadjipetrou; V Senchuk
Journal:  Arzneimittelforschung       Date:  1998-07

10.  Histoplasma capsulatum synthesizes melanin-like pigments in vitro and during mammalian infection.

Authors:  Joshua D Nosanchuk; Beatriz L Gómez; Sirida Youngchim; Soraya Díez; Philip Aisen; Rosely M Zancopé-Oliveira; Angela Restrepo; Arturo Casadevall; Andrew J Hamilton
Journal:  Infect Immun       Date:  2002-09       Impact factor: 3.441

View more
  70 in total

Review 1.  Impact of melanin on microbial virulence and clinical resistance to antimicrobial compounds.

Authors:  Joshua D Nosanchuk; Arturo Casadevall
Journal:  Antimicrob Agents Chemother       Date:  2006-11       Impact factor: 5.191

2.  Effects of antifungal interventions on the outcome of experimental infections with phenotypic switch variants of Cryptococcus neoformans.

Authors:  Bettina C Fries; Emily Cook; Xiabo Wang; Arturo Casadevall
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

3.  Smoking, melanization, and cryptococcosis: is there a connection?

Authors:  Z U Khan
Journal:  J Clin Microbiol       Date:  2006-03       Impact factor: 5.948

4.  Detection of antibodies against Paracoccidioides brasiliensis melanin in in vitro and in vivo studies during infection.

Authors:  Martha E Urán; Joshua D Nosanchuk; Angela Restrepo; Andrew J Hamilton; Beatriz L Gómez; Luz E Cano
Journal:  Clin Vaccine Immunol       Date:  2011-08-03

Review 5.  Resistance to echinocandin-class antifungal drugs.

Authors:  David S Perlin
Journal:  Drug Resist Updat       Date:  2007-06-13       Impact factor: 18.500

6.  Novel application of the masson-fontana stain for demonstrating Malassezia species melanin-like pigment production in vitro and in clinical specimens.

Authors:  George Gaitanis; Vassiliki Chasapi; Aristea Velegraki
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

7.  Antifungal therapeutics for dimorphic fungal pathogens.

Authors:  Kristie D Goughenour; Chad A Rappleye
Journal:  Virulence       Date:  2016-09-19       Impact factor: 5.882

8.  Melanin from Fonsecaea pedrosoi induces production of human antifungal antibodies and enhances the antimicrobial efficacy of phagocytes.

Authors:  Daniela S Alviano; Anderson J Franzen; Luiz R Travassos; Carla Holandino; Sonia Rozental; Regina Ejzemberg; Celuta S Alviano; Marcio L Rodrigues
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

Review 9.  Histoplasma capsulatum at the host-pathogen interface.

Authors:  Joshua D Nosanchuk; Attila Gacser
Journal:  Microbes Infect       Date:  2008-07-10       Impact factor: 2.700

10.  Biosynthesis and functions of a melanoid pigment produced by species of the sporothrix complex in the presence of L-tyrosine.

Authors:  Rodrigo Almeida-Paes; Susana Frases; Glauber de Sousa Araújo; Manoel Marques Evangelista de Oliveira; Gary J Gerfen; Joshua D Nosanchuk; Rosely Maria Zancopé-Oliveira
Journal:  Appl Environ Microbiol       Date:  2012-10-05       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.